Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-21 @ 6:36 PM
Study NCT ID:
NCT02357420
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2015-01-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Sponsor:
Allergan
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RM-131-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None